Medical Developments International | MVP - Fremdkapital

Aktienkurs
0.44
Täglich Wechseln
-0.02 -4.35%
Monatlich
12.82%
Jährlich
-22.81%
Q2 Prognose
0.51




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Genetic Signatures AUD 94K 258K 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Medical Developments International AUD 1.5M 167K 2025-12
Organon & Co USD 8.78B 117M 2025-09
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Starpharma Holdings AUD 1.14M 410K 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12